FDA clears NMT's STARFlex cardiac implant

04/9/2009 | Boston Globe (tiered subscription model), The

The FDA has granted premarket approval to NMT Medical for its STARFlex cardiac septal repair implant designed for patients with ventricular septal defects. The Boston-based device maker develops implant technologies for minimally invasive catheter-based procedures for treating structural defects in the heart.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC